Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.

Fu, S; Hirte, H; Welch, S; Ilenchuk, T T; Lutes, T; Rice, C; Fields, N; Nemet, A; Dugourd, D; Piha-Paul, S; Subbiah, V; Liu, L; Gong, J; Hong, D; Stewart, J M

Fu, S; Hirte, H; Welch, S; Ilenchuk, T T; Lutes, T; Rice, C; Fields, N; Nemet, A; Dugourd, D; Piha-Paul, S; Subbiah, V; Liu, L; Gong, J; Hong, D; Stewart, J M.

Afiliação

Fu S; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Hirte H; Juravinski Cancer Centre, Hamilton, ON, Canada.
Welch S; London Health Sciences Centre, London, ON, Canada.
Ilenchuk TT; Soricimed Biopharma Inc., Moncton, NB, Canada.
Lutes T; Soricimed Biopharma Inc., Moncton, NB, Canada.
Rice C; Soricimed Biopharma Inc., Moncton, NB, Canada.
Fields N; Sagecon Inc., Oakville, ON, Canada.
Nemet A; CLINSIG Research Consulting Inc., Brampton, ON, Canada.
Dugourd D; Soricimed Biopharma Inc., Moncton, NB, Canada.
Piha-Paul S; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Subbiah V; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Liu L; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Gong J; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Hong D; Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
Stewart JM; Soricimed Biopharma Inc., Moncton, NB, Canada. jstewart@soricimed.com.

Invest New Drugs ; 35(3): 397, 2017 06.

Article em En | MEDLINE | ID: mdl-28389981

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Invest New Drugs Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google